Visceral leishmaniasis relapse in Southern Sudan (1999-2007): A retrospective study of risk factors and trends

PLoS Neglected Tropical Diseases

Volumn 4, Issue 6, 2010, Pages

  Gorski, Stanislaw ^a   Collin, Simon M ^b   Ritmeijer, Koert ^a   Keus, Kees ^a   Gatluak, Francis ^a   Mueller, Marius ^a   Davidson, Robert N ^c  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PAROMOMYCIN; STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HEALTH CARE ACCESS; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; PRESCHOOL CHILD; RELAPSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; SPLENOMEGALY; SUDAN; SURVIVAL RATE; TREATMENT DURATION; TREND STUDY; VISCERAL LEISHMANIASIS; AGE; CHI SQUARE DISTRIBUTION; ORGAN SIZE; PATHOLOGY; RECURRENT DISEASE; RISK FACTOR; SPLEEN; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; LOGISTIC MODELS; MALE; ORGAN SIZE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SPLEEN; SUDAN;

EID: 77956985760     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000705     Document Type: Article

References (31)

1. Zijlstra EE, el-Hassan AM (2001) Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95 Suppl 1: S27-S58.
2. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, et al. (2002) Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2: 494-501.
3. Collin S, Davidson R, Ritmeijer K, Keus K, Melaku Y, et al. (2004) Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis 38: 612-619.
4. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL (1996) Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med 124: 664-672.
5. Lyons S, Veeken H, Long J (2003) Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop Med Int Health 8: 733-739.
6. Marlet MV, Sang DK, Ritmeijer K,Muga RO, Onsongo J, et al. (2003) Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01. Trans R Soc Trop Med Hyg 97: 515-518.
7. Mueller M, Balasegaram M, Koummuki Y, Ritmeijer K, Santana MR, et al. (2006) A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan. J Antimicrob Chemother 58: 811-815.
8. Collin SM, Coleman PG, Ritmeijer K, Davidson RN (2006) Unseen Kala-azar deaths in south Sudan (1999-2002). Trop Med Int Health 11: 509-512.
9. Melaku Y, Collin SM, Keus K, Gatluak F, Ritmeijer K, et al. (2007) Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy. Am J Trop Med Hyg 77: 89-94.
10. Mueller M, Ritmeijer K, Balasegaram M, Koummuki Y, Santana MR, et al. (2007) Unresponsiveness to AmBisome in some Sudanese patients with kalaazar. Trans R Soc Trop Med Hyg 101: 19-24.
11. ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN (2008) Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome. Clin Infect Dis 46: 1702-1709.
12. Spiegel PB, Bennedsen AR, Claass J, Bruns L, Patterson N, et al. (2007) Prevalence of HIV infection in conflict-affected and displaced people in seven sub-Saharan African countries: a systematic review. Lancet 369: 2187-2195.
13. World Health Organisation (1996) Manual on Visceral Leishmaniasis Control. WHO, Geneva.
14. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, et al. (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85: 660-667.
15. Hackett LW (1944) Spleen measurement in malaria. J Nat Malar Soc 3: 121-123.
16. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19: 335-351.
17. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M (2006) A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ 333: 723-727.
18. Veeken H, Ritmeijer K, Seaman J, Davidson R (2003) Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in Sudan. Trop Med Int Health 8: 164-167.
19. Santos MA, Marques RC, Farias CA, Vasconcelos DM, Stewart JM, et al. (2002) Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis. Rev Soc Bras Med Trop 35: 629-633.
20. Stanley AC, Engwerda CR (2007) Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85: 138-147.
21. Engwerda CR, Ato M, Cotterell SE, Mynott TL, Tschannerl A, et al. (2002) A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. Am J Pathol 161: 429-437.
22. Veress B, Omer A, Satir AA, El Hassan AM (1977) Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology 33: 605-610.
23. Engwerda CR, Ato M, Kaye PM (2004) Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol 20: 524-530.
24. Malla N, Mahajan RC (2006) Pathophysiology of visceral leishmaniasis - some recent concepts. Indian J Med Res 123: 267-274.
25. Khalil EA, El Hassan AM, Zijlstra EE, Hashim FA, Ibrahim ME, et al. (1998) Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Ann Trop Med Parasitol 92: 151-158.
26. Chunge CN, Owate J, Pamba HO, Donno L (1990) Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans R Soc Trop Med Hyg 84: 221-225.
27. Seaman J, Pryce D, Sondorp HE, Moody A, Bryceson AD, et al. (1993) Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J Infect Dis 168: 715-720.
28. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Messick C, et al. (2000) Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans R Soc Trop Med Hyg 94: 432-433.
29. Mudawi AM (2009) New treatments for visceral leishmaniasis in East Africa: The story so far. 4th World Congress on Leishmaniasis.
30. Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, et al. (2006) A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis 43: 357-364.
31. Thakur CP, Kumar M, Kumar P, Mishra BN, Pandey AK (1988) Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study. Br Med J (Clin Res Ed) 296: 1557-1561.